MacLean, R. C. & San Millan, A. The evolution of antibiotic resistance. Science 365, 1082–1083 (2019).
Andersson, D. I. et al. Antibiotic resistance: turning evolutionary principles into clinical reality. FEMS Microbiol. Rev. 44, 171–188 (2020).
Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260–271 (2010).
Shepherd, M. et al. Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance. Nat. Rev. Microbiol. 22, 650–665 (2024).
Souque, C., Gonzalez Ojeda, I. & Baym, M. From petri dishes to patients to populations: scales and evolutionary mechanisms driving antibiotic resistance. Annu Rev. Microbiol 78, 361–382 (2024).
Hughes, D. & Andersson, D. I. Evolutionary trajectories to antibiotic resistance. Annu. Rev. Microbiol. 71, 579–596 (2017).
Leshchiner, D. et al. A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance. Nat. Commun. 13, 3165 (2022).
Levin-Reisman, I. et al. Antibiotic tolerance facilitates the evolution of resistance. Science 355, 826–830 (2017).
Liu, J., Gefen, O., Ronin, I., Bar-Meir, M. & Balaban, N. Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science 367, 200 (2020).
Levin-Reisman, I., Brauner, A., Ronin, I. & Balaban, N. Epistasis between antibiotic tolerance, persistence, and resistance mutations. Proc. Natl. Acad. Sci. USA 116, 14734–14739 (2019).
Alexandersen, N., Nielsen, K., Haeussler, S., Bjarnsholt, T. & Schonning, K. Antibiotic tolerance and persistence in clinical isolates of Escherichia coli evaluated by high-resolution time-kill assays. Microbiol. Spectr. 13, e01124-25 (2025).
Xu, J. T., Lin, Y., Cheng, T. & Deng, J. Y. The rv2820c K114N mutation is related with capreomycin tolerance. Tuberculosis 148, 102551 (2024).
Ackermann, M. A functional perspective on phenotypic heterogeneity in microorganisms. Nat. Rev. Microbiol 13, 497–508 (2015).
Alexander, H. & MacLean, R. Stochastic bacterial population dynamics restrict the establishment of antibiotic resistance from single cells. Proc. Natl. Acad. Sci. USA 117, 19455–19464 (2020).
Campey, A., Lapinska, U., Chait, R., Tsaneva-Atanasova, K. & Pagliara, S. Antibiotic resistant bacteria survive treatment by doubling while shrinking. mBio 15, e02375-24 (2024).
Lapinska, U. et al. Fast bacterial growth reduces antibiotic accumulation and efficacy. Elife 11, e74062 (2022).
Coates, J. et al. Antibiotic-induced population fluctuations and stochastic clearance of bacteria. Elife 7, e32976 (2018).
Stine, W., Akiyama, T., Weiss, D. & Kim, M. Lineage-dependent variations in single-cell antibiotic susceptibility reveal the selective inheritance of phenotypic resistance in bacteria. Nat. Commun. 16, 4655 (2025).
Zhang, Y., Kepiro, I., Ryadnov, M. & Pagliara, S. Single cell killing kinetics differentiate phenotypic bacterial responses to different antibacterial classes. Microbiol. Spectr. 11, e03667-22 (2023).
Alexander, H. K. Quantifying stochastic establishment of mutants in microbial adaptation. Microbiology 169, 001365 (2023).
Hernandez-Beltran, J. et al. Plasmid-mediated phenotypic noise leads to transient antibiotic resistance in bacteria. Nat. Commun. 15, 2610 (2024).
Bakshi, S. et al. Tracking bacterial lineages in complex and dynamic environments with applications for growth control and persistence. Nat. Microbiol. 6, 783–791 (2021).
Lee, K. K. et al. Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides. Elife 13, RP99752 (2025).
Lipsitch, M. & Levin, B. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41, 363–373 (1997).
Michel, J., Yeh, P., Chait, R., Moellering, R. & Kishony, R. Drug interactions modulate the potential for evolution of resistance. Proc. Natl. Acad. Sci. USA 105, 14918–14923 (2008).
Stewart, F., Antia, R., Levin, B., Lipsitch, M. & Mittler, J. The population genetics of antibiotic resistance II: analytic theory for sustained populations of bacteria in a community of hosts. Theor. Popul. Biol. 53, 152–165 (1998).
MacLean, R. C., Hall, A. R., Perron, G. G. & Buckling, A. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat. Rev. Genet. 11, 405–414 (2010).
Ma, P. et al. Bacterial droplet-based single-cell RNA-seq reveals antibiotic-associated heterogeneous cellular states. Cell 186, 877–891 e814 (2023).
Balaban, N. Q. et al. Definitions and guidelines for research on antibiotic persistence. Nat. Rev. Microbiol 17, 441–448 (2019).
Fisher, R. A., Gollan, B. & Helaine, S. Persistent bacterial infections and persister cells. Nat. Rev. Microbiol. 15, 453–464 (2017).
Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 14, 320–330 (2016).
Baquero, F. & Levin, B. R. Proximate and ultimate causes of the bactericidal action of antibiotics. Nat. Rev. Microbiol. 19, 123–132 (2021).
Conlon, B. P. et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat. Microbiol. 1, 16051 (2016).
Tuomanen, E., Cozens, R., Tosch, W., Zak, O. & Tomasz, A. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J. Gen. Microbiol 132, 1297–1304 (1986).
Davis, B. D. Studies on nutritionally deficient bacterial mutants isolated by means of penicillin. Experientia 6, 41–50 (1950).
Gale, E. F. & Rodwell, A. W. Amino acid metabolism of penicillin-resistant Staphylococci. J. Bacteriol. 55, 161–167 (1948).
Lubrano, P. et al. Metabolic mutations reduce antibiotic susceptibility of E. coli by pathway-specific bottlenecks. Mol. Syst. Biol. 21, 274–293 (2025).
Lopatkin, A. et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science 371, 799 (2021).
Gullberg, E. et al. Selection of resistant bacteria at very low antibiotic concentrations. Plos Pathogens 7, e1002158 (2011).
Frost, I. et al. Cooperation, competition and antibiotic resistance in bacterial colonies. ISME J. 12, 1582–1593 (2018).
Nicoloff, H., Hjort, K., Levin, B. R. & Andersson, D. I. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat. Microbiol. 4, 504–514 (2019).
Kapel, N., Caballero, J. & MacLean, R. Localized pmrB hypermutation drives the evolution of colistin heteroresistance. Cell Rep. 39, 110929 (2022).
Ma, M. & Kim, M. High-resolution, high-throughput detection of hidden antibiotic resistance with the dilution-and-delay (DnD) susceptibility assay. Nat. Commun. 17, 3641 (2026).
Vogwill, T. & MacLean, R. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evolutionary Appl. 8, 284–295 (2015).
Wheatley, R. et al. Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection. Nat. Commun. 12, 2460 (2021).
Ogunlana, L. et al. Regulatory fine-tuning of mcr-1 increases bacterial fitness and stabilises antibiotic resistance in agricultural settings. ISME J. 17, 2058–2069 (2023).
Gagneux, S. Ecology and evolution of Mycobacterium tuberculosis. Nat. Rev. Microbiol. 16, 202–213 (2018).
Chung, H. et al. Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat. Commun. 13, 1231 (2022).
Jago, M. et al. High-throughput method characterizes hundreds of previously unknown antibiotic resistance mutations. Nat. Commun. 16, 780 (2025).
Santi, I., Manfredi, P., Maffei, E., Egli, A. & Jenal, U. Evolution of antibiotic tolerance shapes resistance development in chronic Pseudomonas aeruginosa infections. mBio 12, 03482–20 (2021).
Fleming, A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of b. Influenzae. Brit. J. Exp. Pathol. 10, 226–236 (1929).
Bigger, J. Treatment of Staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244, 497–500 (1944).
Abraham, E. P. et al. Further observations on penicillin. Lancet 2, 177–189 (1941).
Wheat, P. F. History and development of antimicrobial susceptibility testing methodology. J. Antimicrob. Chemother. 48, 1–4 (2001).
Bradely, J. J., Mayhall, C. G. & Dalton, H. P. Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 13, 1052–1057 (1978).
Best, G. K., Koval, A. V. & Best, N. H. Susceptibility of clinical isolates of Staphylococcus aureus to killing by oxacillin. Can. J. Microbiol 21, 1692–1697 (1975).